Splicing fidelity, enhancers, and disease

Area of Science:

• Molecular Biology
• Genetics
• Biochemistry

Background:

• Eukaryotic gene expression relies on pre-mRNA splicing to generate a diverse proteome from a limited genome.
• Alternative splicing is a tightly regulated process crucial for cellular function.
• Mutations affecting splice sites or regulatory elements, such as enhancers, can lead to aberrant transcripts and disease.

Purpose of the Study:

• To provide an overview of the fundamental splicing reaction in eukaryotes.
• To explain the mechanisms underlying alternative splicing.
• To highlight the role of splicing enhancers in disease when mutations occur.

Main Methods:

• Literature review of splicing mechanisms.
• Analysis of genetic mutations impacting splicing regulatory elements.
• Case studies of diseases caused by enhancer defects.

Main Results:

• Splicing is a complex process involving splice sites and regulatory elements.
• Alternative splicing significantly expands the proteomic diversity.
• Mutations in splicing enhancers are a notable cause of human diseases.

Conclusions:

• Understanding splicing and alternative splicing is key to comprehending gene regulation.
• Defects in splicing enhancers represent a significant class of mutation-related diseases.
• Further research into splicing regulation can reveal new therapeutic targets.